Clearside Biomedical Inc (CLSD)
1.32
+0.01
(+0.76%)
USD |
NASDAQ |
May 17, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical Cash from Financing (Quarterly): 14.34M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.34M |
December 31, 2023 | -0.257M |
September 30, 2023 | 0.317M |
June 30, 2023 | 0.022M |
March 31, 2023 | 0.332M |
December 31, 2022 | 0.575M |
September 30, 2022 | 30.69M |
June 30, 2022 | 0.004M |
March 31, 2022 | 0.065M |
December 31, 2021 | 0.165M |
September 30, 2021 | 2.081M |
June 30, 2021 | 7.117M |
March 31, 2021 | 14.42M |
December 31, 2020 | 6.884M |
September 30, 2020 | 2.429M |
June 30, 2020 | -2.639M |
March 31, 2020 | 1.193M |
December 31, 2019 | -1.645M |
September 30, 2019 | 2.424M |
Date | Value |
---|---|
June 30, 2019 | 1.288M |
March 31, 2019 | 6.628M |
December 31, 2018 | 0.02M |
September 30, 2018 | 0.00 |
June 30, 2018 | 2.741M |
March 31, 2018 | 79.02M |
December 31, 2017 | 0.069M |
September 30, 2017 | 0.001M |
June 30, 2017 | 0.159M |
March 31, 2017 | 5.133M |
December 31, 2016 | 33.48M |
September 30, 2016 | 8.039M |
June 30, 2016 | 44.88M |
March 31, 2016 | 0.00 |
December 31, 2015 | 19.95M |
September 30, 2015 | 0.006M |
June 30, 2015 | 5.988M |
March 31, 2015 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.639M
Minimum
Jun 2020
30.69M
Maximum
Sep 2022
3.990M
Average
0.884M
Median
Cash from Financing (Quarterly) Benchmarks
Cassava Sciences Inc | 22.16M |
Heron Therapeutics Inc | 0.011M |
Actinium Pharmaceuticals Inc | 14.77M |
Karyopharm Therapeutics Inc | -- |
Ocular Therapeutix Inc | 321.22M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -7.851M |
Cash from Investing (Quarterly) | -0.057M |
Free Cash Flow | -20.49M |
Free Cash Flow Per Share (Quarterly) | -0.1132 |
Free Cash Flow to Equity (Quarterly) | -7.908M |
Free Cash Flow Yield | -24.45% |